相关实验视频

Updated: Jun 21, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

获得性无塑性贫血的生殖系变异:当前的知识和未来的前景

Peicheng Wang¹, Wanzhi Jiang¹, Tianyi Lai¹

¹Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang.

|July 11, 2024

概括

遗传倾向在获得的无塑性贫血 (AA) 中起作用. 生殖系变异与突变一起,有助于AA的发展和进展,影响诊断和管理.

科学领域:

血液学血液学血液学
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

无形性贫血 (AA) 是一种骨髓衰竭疾病,具有遗传和获得的形式.
获得的AA通常被认为是免疫介导的,但遗传因素越来越被认可.
以前与遗传性骨髓衰竭综合征相关的生殖线变异,涉及到获得的AA.

研究的目的:

探索获得的AA和生殖系变异之间的关联.
在AA诊断和管理中详细说明生殖系变异的临床意义.
鼓励进一步研究免疫原变异和体质突变的作用.

主要方法:

审查现有的关于无塑性贫血和生殖系遗传学的文献.
分析证据,将生殖系变异与AA病原体联系起来.
讨论诊断和管理方面的影响.

主要成果:

生殖线变异,通常是异合体,对获得的AA发病和进展有显著的贡献.
这些变异与基因稳态,DNA修复和免疫损伤等机制有关.
在TERT和TERC中确定的突变是已知的遗传AA的贡献者.

结论:

生殖线变异对于理解获得的AA至关重要,它超出了随机免疫媒介过程.
生殖系变异的临床意义有助于诊断和管理无塑性贫血.
需要对免疫原变异和潜在的二次体质突变进行进一步的研究.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.